Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

Clinical trial NCT03297606 · RECRUITING

Trial details

NCT number: NCT03297606
Sponsor: Canadian Cancer Trials Group
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Multiple Myeloma Advanced Solid Tumors

Start date: 2018-03-23
Primary completion: 2026-12-31
Enrollment: 720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.